Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001136261-08-000048
Filing Date
2008-03-17
Accepted
2008-03-17 06:27:14
Documents
79
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 10-K form10k.htm 10-K 1518933
3 10-K form10-k.pdf 10-K 832050
4 2005 OMNIBUS INCENTIVE PLAN, AS AMENDED ON DECEMBER 28, 2007 exh10-15a.htm EX-10.15A 75345
5 SEPARATION AGREEMENT DATED JULY 31, 2007 BY AND BETWEEN NPS PHARMACEUTICALS, INC exh10-21.htm EX-10.21 97033
6 ASSET PURCHASE AGREEMENT, DATED OCTOBER 9, 2007 exh10-30.htm EX-10.30 212994
7 SEPARATION AGREEMENT DATED DECEMBER 7, 2007 BY AND BETWEEN NPS PHARMACEUTICALS, exh10-31.htm EX-10.31 97779
8 SEPARATION AGREEMENT DATED NOVEMBER 19, 2007 BY AND BETWEEN NPS PHARMACEUTICALS, exh10-32.htm EX-10.32 22102
9 COMMERCIAL MANUFACTURING AGREEMENT, DATED OCTOBER 18, 2002 exh10-33a.htm EX-10.33A 201078
10 AMENDING AGREEMENT, DATED MARCH 15, 2004 exhibit10-33b.htm EX-10.33B 3514
11 AMENDMENT NUMBER ONE TO AMENDING AGREEMENT exh10-33c.htm EX-10.33C 5724
12 RATIO OF EARNINGS exh12-1.htm EX-12.1 23804
13 SUBSIDIARIES exh21-1.htm EX-21.1 1267
14 CONSENT exh23-1.htm EX-23.1 2655
15 CEO 302 CERTIFICATE exh31-1.htm EX-31.1 6404
16 CFO 302 CERTIFICATE exh31-2.htm EX-31.2 6407
17 906 CERTIFICATE exh32.htm EX-32 2887
18 2005 OMNIBUS INCENTIVE PLAN, AS AMENDED ON DECEMBER 28, 2007 exhibit10-15a.pdf EX-10.15A 75556
19 SEPARATION AGREEMENT DATED JULY 31, 2007 BY AND BETWEEN NPS PHARMACEUTICALS, INC exhibit10-21.pdf EX-10.21 115162
20 ASSET PURCHASE AGREEMENT, DATED OCTOBER 9, 2007 exhibit10-30.pdf EX-10.30 608536
21 SEPARATION AGREEMENT DATED DECEMBER 7, 2007 BY AND BETWEEN NPS PHARMACEUTICALS, exhibit10-31.pdf EX-10.31 114856
22 SEPARATION AGREEMENT DATED NOVEMBER 19, 2007 BY AND BETWEEN NPS PHARMACEUTICALS, exhibit10-32.pdf EX-10.32 55332
23 COMMERCIAL MANUFACTURING AGREEMENT, DATED OCTOBER 18, 2002 exhibit10-33a.pdf EX-10.33A 141644
24 AMENDING AGREEMENT, DATED MARCH 15, 2004 exhibit10-33b.pdf EX-10.33B 1947248
25 AMENDMENT NUMBER ONE TO AMENDING AGREEMENT exhibit10-33c.pdf EX-10.33C 16394
26 RATIO OF EARNINGS exhibit12-1.pdf EX-12.1 7928
27 SUBSIDIARIES exhibit21-1.pdf EX-21.1 16471
28 CONSENT exhibit23-1.pdf EX-23.1 9465
29 CEO 302 CERTIFICATE exhibit31-1.pdf EX-31.1 47647
30 CFO 302 CERTIFICATE exhibit31-2.pdf EX-31.2 57804
31 906 CERTIFICATE exhibit32.pdf EX-32 35937
32 LOGO logo.jpg GRAPHIC 8509
33 exhibit10-33bimg0.jpg GRAPHIC 135841
34 exhibit10-33bimg1.jpg GRAPHIC 492641
35 exhibit10-33bimg2.jpg GRAPHIC 475016
36 exhibit10-33bimg3.jpg GRAPHIC 233515
37 exhibit10-33bimg4.jpg GRAPHIC 439873
38 exhibit10-33bimg5.jpg GRAPHIC 531886
39 exhibit10-33bimg6.jpg GRAPHIC 485960
40 exhibit10-33bimg7.jpg GRAPHIC 459666
41 exhibit10-33bimg8.jpg GRAPHIC 473219
42 exhibit10-33bimg9.jpg GRAPHIC 561385
43 exhibit10-33bimg10.jpg GRAPHIC 355150
44 exhibit10-33bimg11.jpg GRAPHIC 503997
45 exhibit10-33bimg12.jpg GRAPHIC 528274
46 exhibit10-33bimg13.jpg GRAPHIC 435727
47 exhibit10-33bimg14.jpg GRAPHIC 475768
48 exhibit10-33bimg15.jpg GRAPHIC 510982
49 exhibit10-33bimg16.jpg GRAPHIC 571793
50 exhibit10-33bimg17.jpg GRAPHIC 440975
51 exhibit10-33bimg18.jpg GRAPHIC 553238
52 exhibit10-33bimg19.jpg GRAPHIC 486139
53 exhibit10-33bimg20.jpg GRAPHIC 528373
54 exhibit10-33bimg21.jpg GRAPHIC 552454
55 exhibit10-33bimg22.jpg GRAPHIC 477350
56 exhibit10-33bimg23.jpg GRAPHIC 555608
57 exhibit10-33bimg24.jpg GRAPHIC 498216
58 exhibit10-33bimg25.jpg GRAPHIC 559472
59 exhibit10-33bimg26.jpg GRAPHIC 441163
60 exhibit10-33bimg27.jpg GRAPHIC 459577
61 exhibit10-33bimg28.jpg GRAPHIC 346423
62 exhibit10-33bimg29.jpg GRAPHIC 482602
63 exhibit10-33bimg30.jpg GRAPHIC 476836
64 exhibit10-33bimg31.jpg GRAPHIC 571570
65 exhibit10-33bimg32.jpg GRAPHIC 508570
66 exhibit10-33bimg33.jpg GRAPHIC 434902
67 exhibit10-33bimg34.jpg GRAPHIC 542790
68 exhibit10-33bimg35.jpg GRAPHIC 549720
69 exhibit10-33bimg36.jpg GRAPHIC 553608
70 exhibit10-33bimg37.jpg GRAPHIC 577424
71 exhibit10-33bimg38.jpg GRAPHIC 537790
72 exhibit10-33bimg39.jpg GRAPHIC 550476
73 exhibit10-33bimg40.jpg GRAPHIC 465761
74 exhibit10-33bimg41.jpg GRAPHIC 520919
75 exhibit10-33bimg42.jpg GRAPHIC 538047
76 exhibit10-33bimg43.jpg GRAPHIC 409277
77 exhibit10-33bimg44.jpg GRAPHIC 495959
78 exhibit10-33bimg48.jpg GRAPHIC 399032
79 1998 STOCK OPTION PLAN THRU DECEMBER 2007 exh10-2d.htm EX-10.2D 36944
80 1998 STOCK OPTION PLAN THRU DECEMBER 2007 exhibit10-2d.pdf EX-10.2D 73060
  Complete submission text file 0001136261-08-000048.txt   38628432
Mailing Address 550 HILLS DRIVE BEDMINSTER NJ 07921
Business Address 550 HILLS DRIVE BEDMINSTER NJ 07921 (908) 450-5300
NPS PHARMACEUTICALS INC (Filer) CIK: 0000890465 (see all company filings)

EIN.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23272 | Film No.: 08691123
SIC: 2836 Biological Products, (No Diagnostic Substances)